EUVIMEDEUVIMED entdecken
Crossref

COF‐SO 3 H‐Catalyzed Synthesis of Pyrazoline‐Pyridine Hybrids with Dual Antioxidant and Anti‐Inflammatory Activity Targeting PDE4B

Nida Khan iD, Mohd Kamil Hussain iD, Mohammad Faheem Khan iD, Zeba N Siddiqui iD

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202402457 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Nida Khan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Green Chemistry Laboratory, Organic Chemistry Division, Department of Chemistry, Aligarh Muslim University, Aligarh, 202002, India. Hauptthemen laut MEDLINE: Cyclic Nucleotide Phosphodiesterases, Type 4, Pyrazoles, Pyridines, Antioxidants. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study explores new anti‐inflammatory agents by synthesizing pyrazoline‐pyridine hybrids with N‐butylsulfonated covalent organic framework (COF‐SO 3 H) as a recyclable catalyst, achieving excellent yields in just one minute. The protocol was successfully scaled up to a multi‐gram scale, highlighting its robustness and efficiency, and it operates without the need for column chromatography. Among the synthesized hybrids, compound 5d , a pyrazoline‐pyridine hybrid bearing an indole moiety, emerged as a potent anti‐inflammatory and antioxidant agent. It effectively inhibited PDE4B activation with an IC 50 value of 99.38 nM, without adversely affecting HEK cells. Compound 5d demonstrated its dual activity by significantly reducing ROS production and restoring mitochondrial health in LPS‐stimulated A549 and HEK cells, while also downregulating IL‐1β and NF‐ĸB/p65 expression in LPS‐stimulated A549 cells. In silico studies confirmed compound 5d ’s strong binding to PDE4B, with stable RMSD and RMSF values, indicating its potential as a stable and effective PDE4B inhibitor. The compound exhibited favorable physicochemical properties, met drug‐likeness criteria, and showed low toxicity as predicted in silico. These findings suggest that compound 5d has significant potential as a therapeutic agent for inflammatory diseases due to its dual anti‐inflammatory and antioxidant activities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclic Nucleotide Phosphodiesterases, Type 4PyrazolesPyridinesAntioxidantsPhosphodiesterase 4 InhibitorsHumansCatalysisLipopolysaccharidesStructure-Activity RelationshipMolecular StructureA549 CellsAnti-Inflammatory AgentsReactive Oxygen SpeciesHEK293 CellsMolecular Docking SimulationDose-Response Relationship, DrugAnti-Inflammatory Agents, Non-Steroidal

Stichwörter der Autor:innen

Anti-inflammatoryCOF-SO3HNSAIDsPDE4B inhibitorsPyrazoline

Substanzen

Cyclic Nucleotide Phosphodiesterases, Type 4PyrazolesPyridinesAntioxidantsPDE4B protein, humanPhosphodiesterase 4 InhibitorsLipopolysaccharidesAnti-Inflammatory AgentsReactive Oxygen Speciespyridine

Autor:innen und Institutionen

  • Green Chemistry Laboratory, Organic Chemistry Division, Department of Chemistry, Aligarh Muslim University, Aligarh, 202002, India.
  • Department of Chemistry, Govt. Raza P.G. College, Rampur, 244901, India.
  • Department of Biotechnology, Era's Lucknow Medical College, Era University, Lucknow, 226003, India.

ORCID-Profile: Nida Khan, Mohd Kamil Hussain, Mohammad Faheem Khan, Zeba N Siddiqui

Zitieren

APA

Khan, N., Hussain, M. K., Khan, M. F., & Siddiqui, Z. N. (2025). COF‐SO 3 H‐Catalyzed Synthesis of Pyrazoline‐Pyridine Hybrids with Dual Antioxidant and Anti‐Inflammatory Activity Targeting PDE4B. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202402457

Vancouver

Khan N, Hussain MK, Khan MF, Siddiqui ZN. COF‐SO 3 H‐Catalyzed Synthesis of Pyrazoline‐Pyridine Hybrids with Dual Antioxidant and Anti‐Inflammatory Activity Targeting PDE4B. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202402457

BibTeX
@article{Khan2025,
  author = {Khan, Nida and Hussain, Mohd Kamil and Khan, Mohammad Faheem and Siddiqui, Zeba N},
  title = {COF‐SO 3 H‐Catalyzed Synthesis of Pyrazoline‐Pyridine Hybrids with Dual Antioxidant and Anti‐Inflammatory Activity Targeting PDE4B},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202402457}
}
Kostenlos starten →